Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Ketoconazole and Tretinoin

supplement:

Tretinoin

Research Papers that Mention the Interaction

Culture in the presence of all-trans-retinoic acid decreased the half-life twofold and resulted in an increased sensitivity of retinoic acid degredation to ketoconazole.
Biochemical pharmacology  •  2000  |  View Paper
In both endothelial cells and hepatocytes all-trans-retinoic acid metabolism was inhibitable by the cytochrome P-450 inhibitors liarozole (10 microM) and ketoconazole (10 microM), albeit to different extents and with different specificities.
European journal of biochemistry  •  1997  |  View Paper
It is concluded that the in vivo effect of CYP inhibitors (DEDTC and KC ) on the elimination rate of ATRA is qualitatively different from that expected from in vitro studies.
Farmaco  •  2004  |  View Paper
Metabolism of [3H]-retinoic acid by TA3 Ha cells was inhibited by the cytochrome P-450 inhibitors ketoconazole , clotrimazole, and liarozole.
Journal of pharmacological and toxicological methods  •  1995  |  View Paper
Administration of ketoconazole or R 75 251 (40 mg/kg, -2 hr) to rats also enhanced endogenous plasma concentrations of RA.
injected RA from plasma: the half-life of RA increased from 27 min in control-treated animals to 43 min and 76 min after dosing with ketoconazole and R 75 251, respectively.
The Journal of pharmacology and experimental therapeutics  •  1990  |  View Paper
Ketoconazole and miconazole, imidazole antifungal agents and inhibitors of some fungal and mammalian P450-dependent enzymes, inhibit in vitro RA metabolism by rat epidermal microsomes.
Skin pharmacology : the official journal of the Skin Pharmacology Society  •  1988  |  View Paper
They also suggest that ketoconazole is capable of prolonging the biological half-life of RA and of improving the tissue levels of this compound.
The Journal of pharmacology and experimental therapeutics  •  1988  |  View Paper
An inhibitor of oxidative metabolism, ketoconazole , decreased the rate of retinoic acid metabolism and decreased the concentration of retinoic acid required to produce a half-maximum response.
Proceedings of the National Academy of Sciences of the United States of America  •  1985  |  View Paper